Cancer Vaccines & Immunotherapy

It is presently evident that numerous human tumor antigens can be perceived by the safe framework. These tumor antigens can be characterized into a few gatherings including malignancy testis, separation, tissue, over-communicated, and viral-related antigens. Enhanced comprehension of the science of the insusceptible reaction, especially of safe acknowledgment and initiation of T-cells, permit better plan of antibodies.


  • Antibody-targeted fusion proteins for Cancer Therapy
  • Autoimmunity & Biotechnology
  • Clinical Laboratory Immunology
  • Immune-mediated Neurological Syndromes
  • Immunological aspects of Endocrine diseases & Chronic diseases
  • Immunological aspects of infection
  • Monoclonal antibodies and Organ Cancers
  • Tumor Immunology and Immunotherapy

Related Conference of Cancer Vaccines & Immunotherapy

November 26-27, 2021

33rd Annual Congress on Immunology and Vaccinations

Vancouver, Canada
December 01-02, 2021

41st Global Summit and Expo on Vaccines & Immunology

Frankfurt, Germany
March 09-10, 2022


Geneva, Switzerland
October 07-08, 2022

34th International Conference on Vaccines and Immunization

Zurich, Switzerland

Cancer Vaccines & Immunotherapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in